Hypercalcemia Malignancy Factor (1-34), amide, human corresponds to an N-terminal fragment with an amidated C-terminus that enhances stability. The peptide preserves structural elements important for receptor interaction and signaling studies. Its sequence supports biophysical characterization of helical content and binding interfaces. Researchers employ it in structure-activity analysis and peptide-receptor modeling.
CAT No: P03055
CAS No:112955-31-4
Synonyms/Alias:Hypercalcemia Malignancy Factor (1-34), amide, human;Hypercalcemia of Malignancy Factor (1-34) amide (human, mouse, rat), pTHrP (1-34) amide (human, mouse, rat)
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More